P
Platomics
Provides a regulatory compliant digital infrastructure and network for every laboratory to setup and run genetic tests
About Platomics
Platomics GmbH, a Vienna-based HealthTech and Regulatory Technology (RegTech) company, was established in 2017. The company's genesis is directly linked to the extensive experience of its founders in the diagnostics industry. Albert Missbichler, with a background in molecular biology and prior roles at the Austrian Agency for Health and Food Safety (AGES) and as a lead auditor for medical devices, and Ernst-Arno Lemke, with his experience in quality and risk management for IVD products, identified a critical bottleneck in the industry. Their direct exposure to the burdensome, manual, and document-heavy processes required for regulatory compliance under the new In Vitro Diagnostic Regulation (IVDR) spurred the creation of Platomics.
Read full description
The company targets a significant challenge within the European Union's healthcare sector: the stringent IVDR (EU) 2017/746, which mandates that all in-vitro diagnostic tests, including those developed in-house by laboratories, undergo a rigorous approval process. Platomics serves in-vitro diagnostic manufacturers and clinical laboratories, which face substantial time and resource commitments to meet these compliance requirements. The firm's business model is centered around its proprietary SaaS platform, PlatoX®, designed to digitize and automate these complex regulatory workflows. By shifting the paradigm from manual document management to intelligent data handling, Platomics aims to drastically reduce the administrative burden and associated costs for its clients.
PlatoX® is a comprehensive digital platform that provides a suite of tools for managing the entire lifecycle of IVD regulatory compliance. For manufacturers, it facilitates the creation and maintenance of technical documentation required for CE marking under IVDR. For clinical laboratories developing their own tests, the platform offers dedicated modules to manage performance evaluations and post-market surveillance, ensuring adherence to IVDR standards. A key feature is its marketplace functionality, which connects IVD manufacturers with laboratories. This allows manufacturers to efficiently distribute their technical documentation and performance data, while laboratories can access and utilize this information to streamline the validation of their own diagnostic tests. This collaborative ecosystem is designed to accelerate the time-to-market for new diagnostic solutions and ensure patient access to necessary tests.
At a glance
- Status
- Operational
- Founded
- 2014
- Headquarters
- Vienna, Austria
- Employees
- 67
- Open positions
- None listed
- Dealroom signal
- 60.5/100
- Industry
- Health
- Sub-industry
- BioTechnology
- Sector
- Biotech & Life Sciences, Biotechnology, Genetics and genomics, Precision Medicine, Tech for Biotech and Pharma, Tech for Hospitals and Clinics, Seal of Excellence EC, Horizon Europe, Digital Pharma
- Business model
- SaaS
- Client focus
- b2b
Latest news
Press, funding announcements and product moves mentioning Platomics.
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | Sep 2021 | $15M | $62M | GreyBird Ventures | — |
| SERIES A✓Equity / VC | Aug 2019 | $1.1M | $4.4M | Undisclosed | — |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for Platomics is 830 monthly website visits, down 68.1% over the last three months. Platomics's team declined 13% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
GreyBird Ventures
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Platomics on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Platomics’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.